KalVista Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Framingham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
KalVista Pharmaceuticals, Inc. has filed 884 SEC EDGAR filings since 29 Dec 2005

SEC filing history

Showing 176-200 of 882 matching filings.

Per page
25
Current page
8
4

4 filing

Filing date
11 Feb 2025
Reporting date
07 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88797

SCHEDULE 13G/A filing

Filing date
03 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Feb 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
03 Feb 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-284321

S-8

Filing date
16 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Dec 2024
Reporting date
06 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Nov 2024
Reporting date
22 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Nov 2024
Reporting date
22 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Nov 2024
Reporting date
23 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
26 Nov 2024
Reporting date
23 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Nov 2024
Reporting date
17 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Nov 2024
Reporting date
17 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Nov 2024
Reporting date
17 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88797

AMENDMENT NO. 3

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88797

SC 13G/A filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88797

KALVISTA PHARMACEUTICALS, INC.

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88797

SEC SCHEDULE 13G

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88797

SC 13G/A filing

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88797

KALVISTA PHARMACEUTICALS, INC.

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88797

SC 13D/A

Filing date
07 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .